Vir Biotechnology, Inc. Common Stock
Symbol: VIR (NASDAQ)
6.12
▼ (-2.47%) -0.155
Company Description:
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
Key Stats
- Today's Open: $6.21
- Today's High: $6.379
- Today's Low: $6.085
- Today's Volume: 1.29M
- Yesterday Close: $6.27
- Yesterday High: $6.44
- Yesterday Low: $6.12
- Yesterday Volume: 1.01M
- Last Min Volume: 2
- Last Min High: $6.115
- Last Min Low: $6.115
- Last Min VWAP: $6.115
Company Profile
- Name: Vir Biotechnology, Inc. Common Stock
- Website: https://www.vir.bio
- Listed Date: 2019-10-11
- Location: SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001706431
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $871.01M
- Round Lot: 100
- Outstanding Shares: 138.92M
- Asset Type: CS
RECENT FILINGS FOR VIR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-21 | 144 | View |
| 2025-10-17 | 4 | View |
| 2025-10-14 | 4 | View |
| 2025-10-09 | 4 | View |
| 2025-10-07 | 4 | View |
| 2025-10-03 | 144 | View |
| 2025-10-02 | 4 | View |
| 2025-10-01 | 144 | View |
| 2025-09-03 | 4 | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-08-04 | 4 | View |
| 2025-07-24 | 8-K | View |
| 2025-07-17 | 4 | View |
| 2025-07-17 | 144 | View |
| 2025-07-15 | 144 | View |
| 2025-07-02 | 4 | View |
| 2025-07-01 | 144 | View |
| 2025-06-11 | 144 | View |
| 2025-06-10 | 144 | View |
Latest News on VIR